Peritoneal tuberculosis after immunomodulatory treatment

Ugeskr Laeger. 2023 Mar 20;185(12):V10220604.
[Article in Danish]

Abstract

It is well known that biological treatment increases the risk of opportunistic infections. Guidelines recommend tuberculosis screening prior to treatment. This is a case report of a woman who had morbus Crohn and developed peritoneal tuberculosis even though she completed a preventive tuberculosis eradication before initiating treatment with anti-TNF-inhibitor. She appeared with ascites and was examined very thoroughly, and eventually a peritoneal biopsy revealed tuberculosis. Tuberculosis is difficult to diagnose, and eradication is no guarantee that tuberculosis cannot relapse during biological treatment.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Crohn Disease* / complications
  • Crohn Disease* / diagnosis
  • Crohn Disease* / drug therapy
  • Female
  • Humans
  • Peritoneum
  • Peritonitis, Tuberculous* / diagnosis
  • Tuberculosis* / diagnosis
  • Tuberculosis* / drug therapy
  • Tuberculosis* / prevention & control
  • Tumor Necrosis Factor Inhibitors

Substances

  • Tumor Necrosis Factor Inhibitors